|
⚲
|
| Keyboard |
| Bisgaard Peter
✚
|
|
|---|---|
| CIK # | 0001606387 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001606387] | |
| 4 | [0001606387] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Eargo Inc | |
| Bisgaard Peter | |
| Ra Pharmaceuticals Inc | |
| HTG Molecular Diagnostics Inc | |
| Nevro Corp | |
| Otonomy Inc | |
| Alder Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eargo Inc EAR
Series D Preferred Stock · derivative
|
2020-10-20 | Conversion | 261,701 | $0.00 | |
|
Eargo Inc EAR
Common Stock
|
2020-10-20 | Conversion | 41,969 | ||
|
Eargo Inc EAR
Common Stock
|
2020-10-20 | Buy | 222,222 | $18.00 | 3,999,996 |
|
Eargo Inc EAR
Common Stock
|
2020-10-20 | Conversion | 2,664,502 | ||
|
Eargo Inc EAR
Series E Preferred Stock · derivative
|
2020-10-20 | Conversion | 24,907 | $0.00 | |
|
Eargo Inc EAR
Series E Preferred Stock · derivative
|
2020-10-20 | Conversion | 849,858 | $0.00 | |
|
Eargo Inc EAR
Series C Preferred Stock · derivative
|
2020-10-20 | Conversion | 11,086 | $0.00 | |
|
Eargo Inc EAR
Series C Preferred Stock · derivative
|
2020-10-20 | Conversion | 1,330,361 | $0.00 | |
|
Eargo Inc EAR
Series D Preferred Stock · derivative
|
2020-10-20 | Conversion | 3,738 | $0.00 | |
|
Eargo Inc EAR
Stock Option (Right to Buy) · derivative
|
2020-10-15 | Grant | 6,666 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Options to Purchase Common Stock · derivative
|
2018-06-28 | Grant | 15,000 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Options to Purchase Common Stock · derivative
|
2017-10-26 | Grant | 15,000 | $0.00 |